Effects of pomegranate juice on blood pressure: A systematic review and meta-analysis of randomized controlled trials

Pharmacological Research

Volumn 115, Issue , 2017, Pages 149-161

  Sahebkar, Amirhossein ^a,b   Ferri, Claudio ^c   Giorgini, Paolo ^c   Bo, Simona ^d   Nachtigal, Petr ^e   Grassi, Davide ^c  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF L'AQUILA   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

^e Charles University in Prague Faculty of Pharmacy   (Czech Republic)

Author keywords

Antioxidants; Blood pressure; Cardiovascular risk; Flavonoids; Pomegranate

Indexed keywords

PLACEBO; ANTIHYPERTENSIVE AGENT;

ARTICLE; BLOOD PRESSURE REGULATION; DATA SYNTHESIS; DIASTOLIC BLOOD PRESSURE; FOOD INTAKE; HUMAN; META ANALYSIS (TOPIC); POMEGRANATE JUICE; PRIORITY JOURNAL; QUALITY CONTROL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW (TOPIC); SYSTOLIC BLOOD PRESSURE; BLOOD PRESSURE; CHEMISTRY; DRUG EFFECTS; FOOD; FRUIT AND VEGETABLE JUICE; HYPERTENSION; LYTHRACEAE; META ANALYSIS;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; FOOD; FRUIT AND VEGETABLE JUICES; HUMANS; HYPERTENSION; PUNICACEAE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84999188049     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2016.11.018     Document Type: Article

References (38)

1. [1] Mancia, G., Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 31:7 (2013), 1281–1357.
2. [2] Lawes, C.M., Vander Hoorn, S., Law, M.R., Elliott, P., MacMahon, S., Rodgers, A., Blood pressure and the global burden of disease: part II. Estimates of attributable burden. J. Hypertens. 24 (2006), 423–430.
3. [3] Wang, X., Ouyang, Y., Liu, J., Zhu, M., Zhao, G., Bao, W., Hu, F.B., Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies. BMJ, 349, 2014, g4490.
4. [4] Eilat-Adar, S., Sinai, T., Yosefy, C., Henkin, Y., Nutritional recommendations for cardiovascular disease prevention. Nutrients 5:9 (2013), 3646–3683.
5. [5] Grassi, D., Desideri, G., Ferri, C., Flavonoids: antioxidants against atherosclerosis. Nutrients 2:8 (2010), 889–902.
6. [6] Grassi, D., Desideri, G., Croce, G., Tiberti, S., Aggio, A., Ferri, C., Flavonoids, vascular function and cardiovascular protection. Curr. Pharm. Des. 15:10 (2009), 1072–1084.
7. [7] Grassi, D., Desideri, G., Ferri, C., Blood pressure and cardiovascular risk: what about cocoa and chocolate?. Arch. Biochem. Biophys. 501:1 (2010), 112–115.
8. [8] Grassi, D., Desideri, G., Di Giosia, P., De Feo, M., Fellini, E., Cheli, P., Ferri, L., Ferri, C., Tea, flavonoids, and cardiovascular health: endothelial protection. Am. J. Clin. Nutr. 98:6 Suppl (2013), 1660S–1666S.
9. [9] Chong, M.F., Macdonald, R., Lovegrove, J.A., Fruit polyphenols and CVD risk: a review of human intervention studies. Br. J. Nutr. 104:Suppl. 3 (2010), S28–39.
10. [10] http://www.prisma-statement.org/2.1.2%20-%20PRISMA%202009%20Checklist.pdf.
11. [11] Higgins, J.P.T., Green, S., (eds.) Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.2, 2009, The Cochrane Collboration, London.
12. [12] Borenstein, M., Hedges, L., Higgins, J., Rothstein, H., Comprehensive Meta-analysis Version 2. 2005, Biostat, Englewood, NJ.
13. [13] Sahebkar, A., Does PPARγ2 gene Pro12Ala polymorphism affect nonalcoholic fatty liver disease risk? Evidence from a meta-analysis. DNA Cell Biol. 32:4 (2013), 188–198.
14. [14] Sahebkar, A., Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? evidence from a meta-analysis. Phytother. Res. 28:5 (2014), 633–642.
15. [15] Ferretti, G., Bacchetti, T., Sahebkar, A., Effect of statin therapy on paraoxonase-1 status: a systematic review and meta-analysis of 25 clinical trials. Prog. Lipid Res., 2015 S0163-7827(15)00041-7.
16. [16] Duval, S., Tweedie, R., Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56:June (2) (2000), 455–463.
17. [17] Aviram, M., Rosenblat, M., Gaitini, D., Nitecki, S., Hoffman, A., Dornfeld, L., Volkova, N., Presser, D., Attias, J., Liker, H., et al. Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation. Clin. Nutr. 23:3 (2004), 423–433.
18. [18] Sumner, M.D., Elliott-Eller, M., Weidner, G., Daubenmier, J.J., Chew, M.H., Marlin, R., Raisin, C.J., Ornish, D., Effects of pomegranate juice consumption on myocardial perfusion in patients with coronary heart disease. Am. J. Cardiol. 96:6 (2005), 810–814.
19. [19] Davidson, M.H., Maki, K.C., Dicklin, M.R., Feinstein, S.B., Witchger, M., Bell, M., McGuire, D.K., Provost, J.C., Liker, H., Aviram, M., Effects of consumption of pomegranate juice on carotid intima-media thickness in men and women at moderate risk for coronary heart disease. Am. J. Cardiol. 104:7 (2009), 936–942.
20. [20] Lynn, A., Hamadeh, H., Leung, W.C., Russell, J.M., Barker, M.E., Effects of pomegranate juice supplementation on pulse wave velocity and blood pressure in healthy young and middle-aged men and women. Plant Foods Hum. Nutr. 67:3 (2012), 309–314.
21. [21] Tsang, C., Smail, N.F., Almoosawi, S., Davidson, I., Al-Dujaili, E.A., Intake of polyphenol-rich pomegranate pure juice influences urinary glucocorticoids, blood pressure and homeostasis model assessment of insulin resistance in human volunteers. J. Nutr. Sci., 1, 2012, e9.
22. [22] Sohrab, G., Nasrollahzadeh, J., Zand, H., Amiri, Z., Tohidi, M., Kimiagar, M., Effects of pomegranate juice consumption on inflammatory markers in patients with type 2 diabetes: a randomized, placebo-controlled trial. J. Res. Med. Sci. 19:3 (2014), 215–220.
23. [23] Asgary, S., Sahebkar, A., Afshani, M.R., Keshvari, M., Haghjooyjavanmard, S., Rafieian-Kopaei, M., Clinical evaluation of blood pressure lowering, endothelial function improving, hypolipidemic and anti-inflammatory effects of pomegranate juice in hypertensive subjects. Phytother. Res. 28:2 (2014), 193–199.
24. [24] Shema-Didi, L., Kristal, B., Sela, S., Geron, R., Ore, L., Does Pomegranate intake attenuate cardiovascular risk factors in hemodialysis patients?. Nutr. J., 13, 2014, 18.
25. [25] Sleight, P., Yusuf, S., Pogue, J., Tsuyuki, R., Diaz, R., Probstefield, J., for the heart outcomes prevention evaluation (HOPE) study investigators. blood-pressure reduction and cardiovascular risk in HOPE study. Lancet 358 (2001), 2130–2131.
26. [26] The Blood Pressure Lowering Treatment Trialists’ Collaboration, Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data. Lancet 384 (2014), 591–598.
27. [27] Sundström, J., Arima, H., Jackson, R., Turnbull, F., Rahimi, K., Chalmers, J., Woodward, M., Neal, B., On the behalf of the Blood Pressure Lowering Treatment Trialists’ Collaboration, Effects of blood pressure reduction in mild hypertension. A systematic review and meta-analysis. Ann. Intern. Med. 162 (2015), 184–191.
28. [28] Lewington, S., Clarke, R., Qizilbash, N., Peto, R., Collins, R., Prospective Studies C. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360 (2002), 1903–1913.
29. [29] Reboldi, G., Gentile, G., Angeli, F., Ambrosio, G., Mancia, G., Verdecchia, P., Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73,913 patients. J. Hypertens. 29 (2011), 1253–1269.
30. [30] Law, M.R., Morris, J.K., Wald, N.J., Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ, 338, 2009, b1665.
31. [31] Griendling, K.K., FitzGerald, G.A., Oxidative stress and cardiovascular injury: part II: animal and human studies. Circulation 108:17 (2003), 2034–2040.
32. [32] Grassi, D., Desideri, G., Ferri, C., Cardiovascular risk and endothelial dysfunction: the preferential route for atherosclerosis. Curr. Pharm. Biotechnol. 12:9 (2011), 1343–1353.
33. [33] de Nigris, F., Williams-Ignarro, S., Botti, C., Sica, V., Ignarro, L.J., Napoli, C., Pomegranate juice reduces oxidized low-density lipoprotein downregulation of endothelial nitric oxide synthase in human coronary endothelial cells. Nitric Oxide, 15, 2006, 259e63.
34. [34] Faria, A., Calhau, C., The bioactivity of pomegranate: impact on health and disease. Crit. Rev. Food Sci. Nutr. 51:7 (2011), 626–634.
35. [35] Kelishadi, R., Gidding, S.S., Hashemi, M., Hashemipour, M., Zakerameli, A., Poursafa, P., Acute and long term effects of grape and pomegranate juice consumption on endothelial dysfunction in pediatric metabolic syndrome. J. Res. Med. Sci. 16:March (3) (2011), 245–253.
36. [36] Mohan, M., Waghulde, H., Kasture, S., Effect of pomegranate juice on Angiotensin II-induced hypertension in diabetic Wistar rats. Phytother. Res. 24:Suppl. 2 (2010), S196–S203.
37. [37] Aviram, M., Dornfeld, L., Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure. Atherosclerosis 158:1 (2001), 195–198.
38. [38] Kojadinovic, et al. J. Sci. Food Agric.(August (1)), 2016, 10.1002/jsfa.7977.